News - Production


Current filters:


Popular Filters

73 to 97 of 257 results

UK CDMO Aesica unveils a new £30m high capacity manufacturing facility


UK contract development and manufacturing organization (CDMO) Aesica Pharmaceuticals has announced the…

Aesica PharmaceuticalsDiabetesEuropePharmaceuticalProduction

Ban on FDA-regulated drugs from Ranbaxy's Mohali plant


There was another blow for India's largest drugmaker Ranbaxy Laboratories (BSE: 500359) yesterday (September…

Asia-PacificDaiichi SankyoGenericsNorth AmericaProductionRanbaxy LaboratoriesRegulation

Advance Pharmaceutical to invest $25 million in building plant in Russia


USA-based privately-held drugmaker Advance Pharmaceutical Inc is considering establishing a facility…

Advance PharmaceuticalEuropeFinancialGenericsPharmaceuticalProduction

Russia's Cytomed opens new factory in Finland


Cytomed, one of Russia's leading drugmakers, has officially opened its new factory in Finland. The new…


Eisai's EMEA operation cleared as US supplier of Fycompa in USA


The US Food and Drug Administration has approved the US supply of Japanese pharma major Eisai's (TYO:…

EisaiFycompaNeurologicalNorth AmericaPharmaceuticalProduction

Russian pharma market will continue to focus on imports over next few years


The Russian pharmaceutical market will continue to focus on imports during the next several years, despite…

EuropeMarkets & MarketingPharmaceuticalProduction

Theravance reintroduces Vibativ in USA


US drug developer Theravance (Nasdaq: THRX) says it has commenced shipments of Vibativ (telavancin) into…

Antibiotics and Infectious diseasesAstellas PharmaMarkets & MarketingNorth AmericaPharmaceuticalProductionTheravanceVibativ

Dainippon Sumitomo establishes regenerative and cellular medicine office


Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says that it has set up the Regenerative &…

Asia-PacificBiotechnologyDainippon Sumitomo PharmaPharmaceuticalProductionResearch

Low development costs make China attractive for pharma outsourcing


China remains an attractive target for pharmaceutical research and manufacturing, and major players from…


Strategic alliance for pharmaceutical contract research and manufacturing in China


Taiwanese active pharmaceutical ingredients (APIs) maker ScinoPharm (Changshu) Pharmaceuticals (TSE:…

Asia-PacificGenericsProductionResearchScinoPharmSundai MediTech

Mitsubishi Tanabe unit to build new plant in China


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) says that one of its subsidiaries, Tianjin Tanabe…

Asia-PacificMitsubishi TanabePharmaceuticalProduction

US firms establish strategic partnership around biosimilars


Privately-held Oncobiologics has formed a broad strategic partnership with fellow USA-based inVentiv…

AvastinBiotechnologyErbituxGenericsHerceptinHumiraImmunologicalsinVentive HealthOncobiologicsOncologyProductionResearchRituxan

Thermo Fisher Scientific opens its first dry powder media facility in APAC region


USA-based science service company Thermo Fisher Scientific (NYSE: TMO) revealed that it is expanding…

Asia-PacificBiotechnologyProductionThermo Fisher Scientific

Sanofi to produce avanafil for Vivus


US drugmaker Vivus (Nasdaq: VVUS) says it has entered into a commercial supply agreement with French…

avanafilMen's HealthPharmaceuticalProductionSanofiSpedraVivus

Bioran to invest $427 million in building Russia's largest insulin plant


Russian biotechnology company Bioran plans to invest up to 14 billion roubles ($427 million) in the establishment…


Amerigen collaborates with Forest Labs


US generics drugmaker Amerigen Pharmaceuticals has entered into a collaboration agreement with Forest…

Amerigen PharmaceuticalsForest LaboratoriesGenericsNorth AmericaProduction

Leading Ukrainian drug producer plans global expansion


Farmak, one of Ukraine's largest drug producers, plans to significantly expand its sales and production…


Bristol-Myers partners with South Korean firm on biopharma production


US pharma major Bristol-Myers Squibb (NYSE: BMY) has entered into a 10-year agreement under which Samsung…

Asia-PacificBiotechnologyBristol-Myers SquibbOncologyPharmaceuticalProductionSamsung BioLogics

Analyst's view on Irish pharma export woes


Following the news that Ireland's pharmaceutical industry has experienced a sharp fall in exports due…

EuropeMarkets & MarketingPatentsPharmaceuticalProduction

Piramal invests in UK ADC capacity


India-based drugmaker Piramal Healthcare (BSE: 500302) says that it is to invest $2.5 million at its…

EuropeFinancialGenericsPiramal HealthcareProduction

Biological E's Japanese Encephalitis vaccine prequalified by WHO


Indian biopharmaceutical company Biological E (BioE) and European biotech company Valneva (Euronext:…

Biological E LtdBiotechnologyProductionRegulationVaccinesValneva

Kiadis to receive GMP manufacturing license and certificate


Netherlands-based, privately-held clinical stage biopharma company Kiadis Pharma said today (July 24)…

ATIRBiotechnologyEuropeKiadis PharmaProductionRegulation

Venus gets GMP certifications from Ukraine


Indian R&D-based drugmaker Venus Remedies (BSE: 526953) has been able to gain a Good Manufacturing Practice…

Antibiotics and Infectious diseasesAsia-PacificEuropeMarkets & MarketingOncologyPharmaceuticalProductionRegulationVenus Remedies

73 to 97 of 257 results

Back to top